Specialty Pharmaceuticals Industry Financials, Performance and Ratios
-
Industry Score
38.9 /100
Rank 97 out of 131 Industries -
Advance/Decline
12/12
-
No. of Companies24
-
Avg. Market Cap2,242
-
Price to Earning Ratio33.60
-
Price to Earning Growth Ratio0.10
-
Price to Book Ratio6.79
-
Return on Equity16.99
-
Return on Capital Employed-
-
Return on Assets14.97
-
Dividend yield 1 year %0.00
-
Net Profit Growth Annual YoY %86.82 %
-
Net Profit Growth Qtr YoY %57.04 %
-
Net Profit Growth Qtr QoQ %-109.79 %
Show more
*All values are market cap weighted averages.
*All Financial parameters are in Million USD.
Specialty Pharmaceuticals Industry Market Breadth
- < -5%
- -2 to -5%
- 0 to -2%
- 0 to 2%
- 2 to 5%
- > 5%
Specialty Pharmaceuticals Peer comparison
Compare all stocks in Specialty Pharmaceuticals industry listed on stock exchanges
Stock Name | 3M Price Chart | Market Cap | LTPLast Traded Price | Day High Low (%) | Week High Low (%) | Month High Low (%) | Qtr High Low(%) | 1 Year High low(%) | 3 Year High low(%) | 5 Year High low(%) | 10 Year High low(%) |
---|---|---|---|---|---|---|---|---|---|---|---|
Usana Health Sciences Inc |
|
562.0
|
30.2
|
L
 -0.3%
H
30.1
30.8
|
L
 -4.3%
H
30.1
38.3
|
L
 -3.1%
H
30.1
38.3
|
L
 8.2%
H
27.4
38.3
|
L
 -30.5%
H
23.1
45.9
|
L
 -56.7%
H
23.1
73.3
|
L
 -62.9%
H
23.1
107.9
|
L
 -51.8%
H
23.1
138.0
|
Argen X SE - ADR |
|
36,941.5
|
603.6
|
L
 0.8%
H
596.0
606.9
|
L
 5.7%
H
566.4
606.9
|
L
 7.8%
H
510.1
606.9
|
L
 -4.1%
H
510.1
657.4
|
L
 21.0%
H
476.3
678.2
|
L
 65.7%
H
327.7
678.2
|
L
 142.0%
H
212.7
678.2
|
L
H
17.3
678.2
|
Biondvax Pharmaceuticals L... |
|
-
|
2
|
L
 -2.4%
H
1.9
3.5
|
L
 -13.8%
H
1.9
3.5
|
L
 -12.3%
H
1.9
3.5
|
L
 -31.3%
H
1.9
6.2
|
L
 -31.3%
H
1.9
6.2
|
L
 -83.3%
H
0.6
99
|
L
 -99.4%
H
0.6
499.0
|
L
 -95.3%
H
0.6
620
|
Cidara Therapeutics Inc |
|
1,383.2
|
62.5
|
L
 1.0%
H
61.9
63.9
|
L
 1.6%
H
60.7
66.9
|
L
 26.5%
H
44.5
66.9
|
L
 196.1%
H
18.5
66.9
|
L
 379.2%
H
10.1
66.9
|
L
 -80.1%
H
10
840
|
L
 -96.0%
H
10
1736
|
L
 -98.9%
H
10
7228
|
Niagen Bioscience Inc. |
|
760.9
|
9.7
|
L
 -0.3%
H
9.4
9.7
|
L
 2.2%
H
9.2
10.0
|
L
 -32.1%
H
9.2
14.7
|
L
 24.2%
H
7.5
14.7
|
L
 232.0%
H
2.5
14.7
|
L
 461.6%
H
1.2
14.7
|
L
 91.7%
H
1.2
23.7
|
L
 187.5%
H
1.2
23.7
|
Cronos Group Inc |
|
778.5
|
2.0
|
L
 0.5%
H
2
2.0
|
L
 -5.6%
H
2
2.2
|
L
 6.3%
H
1.9
2.2
|
L
 9.2%
H
1.8
2.2
|
L
 -15.5%
H
1.6
2.5
|
L
 -35.9%
H
1.6
3.6
|
L
 -70.1%
H
1.6
15.8
|
L
H
0.2
25.1
|
Enveric Biosciences Inc |
|
3.0
|
1.2
|
L
H
1.2
1.3
|
L
 -12.8%
H
1.2
1.4
|
L
 -0.8%
H
1.2
1.5
|
L
 -9.6%
H
1.1
1.5
|
L
 146%
H
0.3
4.8
|
L
 -80.8%
H
0.3
14.9
|
L
 -99.7%
H
0.3
752
|
L
 -100.0%
H
0.3
67500
|
Flora Growth Corp |
|
14.7
|
0.7
|
L
H
0.6
0.7
|
L
H
0.6
0.7
|
L
 6.6%
H
0.6
0.7
|
L
 8.3%
H
0.5
0.8
|
L
 -38.7%
H
0.4
2.1
|
L
 -94.9%
H
0.4
25.4
|
L
H
0.4
429
|
L
H
0.4
429
|
IM Cannabis Corp |
|
11.0
|
2.7
|
L
 1.9%
H
2.6
2.7
|
L
 -11.7%
H
2.6
3.2
|
L
 3.0%
H
2.4
3.8
|
L
 81.3%
H
1.5
7.1
|
L
 10.6%
H
1.3
7.1
|
L
 -90.9%
H
0.4
49.8
|
L
 -99.0%
H
0.4
697.8
|
L
H
0.4
697.8
|
Lifevantage Corporation |
|
159.7
|
12.7
|
L
 -1.7%
H
12.6
13.1
|
L
 -2.2%
H
12.6
14.9
|
L
H
11.8
14.9
|
L
 2.8%
H
9.8
14.9
|
L
 51.4%
H
7.1
27.4
|
L
 198.6%
H
3.0
27.4
|
L
 -3.3%
H
3.0
27.4
|
L
 239.3%
H
1.4
27.4
|
Mannatech Inc |
|
16.0
|
8.4
|
L
 -10.8%
H
8.1
10.3
|
L
 1.1%
H
7.8
10.3
|
L
 -6.4%
H
7.5
10.3
|
L
 -23.6%
H
7.5
12.0
|
L
 13.9%
H
7
16.5
|
L
 -52.2%
H
6.8
28.0
|
L
 -51.0%
H
6.8
49.1
|
L
 -51.5%
H
6.5
49.1
|
Natural Alternatives Inter... |
|
22.4
|
3.6
|
L
 -4.5%
H
3.6
3.8
|
L
 4.6%
H
3.5
3.8
|
L
 12.7%
H
3.2
3.8
|
L
 17.1%
H
2.7
3.8
|
L
 -37.5%
H
2.6
6.9
|
L
 -64.1%
H
2.6
12.6
|
L
 -46.4%
H
2.6
19.9
|
L
 -40.5%
H
2.6
19.9
|
Nature`s Sunshine Products... |
|
266.1
|
14.4
|
L
 -1.6%
H
14.4
14.6
|
L
 -3.7%
H
14.4
15.2
|
L
 -0.6%
H
14.3
16.2
|
L
 20.4%
H
11.7
16.2
|
L
 -14.7%
H
10.8
18.1
|
L
 37.9%
H
7.9
21.7
|
L
 48.4%
H
7.9
21.7
|
L
 16.7%
H
5.5
21.7
|
Paranovus Entertainment Te... |
|
52.5
|
0.8
|
L
H
0.8
0.8
|
L
 -10.3%
H
0.7
1
|
L
 -7.1%
H
0.7
1
|
L
 -41.8%
H
0.7
1.4
|
L
 -23.5%
H
0.3
1.5
|
L
 -83.2%
H
0.3
6.7
|
L
 -98.3%
H
0.3
51.8
|
L
H
0.3
122
|
PharmaCyte Biotech Inc |
|
6.9
|
1.0
|
L
 -1.0%
H
1.0
1.1
|
L
 2.0%
H
1.0
1.1
|
L
 -1.9%
H
1.0
1.2
|
L
 -18.6%
H
1.0
1.4
|
L
 -49.5%
H
1.0
2.4
|
L
 -57.7%
H
1.0
3.2
|
L
 -94.9%
H
1.0
55.5
|
L
 -99.4%
H
1.0
253.4
|
ProPhase Labs Inc |
|
15.0
|
0.4
|
L
 2.9%
H
0.4
0.4
|
L
 -7.7%
H
0.3
0.5
|
L
 -2.7%
H
0.3
0.5
|
L
 5.9%
H
0.2
0.5
|
L
 -88.4%
H
0.2
3.3
|
L
 -96.5%
H
0.2
13.2
|
L
 -78.4%
H
0.2
16.0
|
L
 -76%
H
0.2
16.0
|
Qualigen Therapeutics Inc |
|
4.1
|
2.5
|
L
 -0.4%
H
2.5
2.6
|
L
 -16.3%
H
2.5
3.1
|
L
 -29.3%
H
2.5
6.7
|
L
 -27.9%
H
2.5
6.7
|
L
 -78.1%
H
0.1
13.4
|
L
 -98.8%
H
0.1
240
|
L
 -99.9%
H
0.1
3600
|
L
 -100.0%
H
0.1
552500
|
Revolution Medicines Inc |
|
6,970.1
|
37.4
|
L
 1.1%
H
37.3
38.0
|
L
 -2.2%
H
36.6
38.8
|
L
 1.4%
H
36.4
39.6
|
L
 -8.0%
H
36.4
43.7
|
L
 -18.5%
H
29.2
62.4
|
L
 65.6%
H
15.5
62.4
|
L
 59.6%
H
14.1
62.4
|
L
H
14.1
62.4
|
Upexi Inc |
|
273.3
|
5.1
|
L
 -6.5%
H
4.8
5.3
|
L
 -34.0%
H
4.8
7.4
|
L
 95.4%
H
2.6
10.6
|
L
 -60.1%
H
2.5
16
|
L
 -29.4%
H
1.9
22.5
|
L
 -94.8%
H
1.9
121.6
|
L
H
1.9
187.4
|
L
H
1.9
187.4
|
Scinai Immunotherapeutics ... |
|
1.6
|
1.6
|
L
 -18.5%
H
1.6
1.7
|
L
 -29.7%
H
1.6
3.5
|
L
 -28.5%
H
1.6
3.5
|
L
 -36.1%
H
1.6
6.2
|
L
 -62.3%
H
1.6
6.2
|
L
 -98.6%
H
1.6
129
|
L
 -99.9%
H
1.6
4989.6
|
L
 -99.6%
H
1.6
6200
|
FitLife Brands Inc |
|
120.1
|
12.8
|
L
 -2.6%
H
12.6
13.4
|
L
 -3.5%
H
12.6
14
|
L
 -0.2%
H
12.5
14.6
|
L
 -17.8%
H
12.3
16.2
|
L
 -61.3%
H
9.8
35.5
|
L
 -22.7%
H
9.8
35.5
|
L
 -22.7%
H
9.8
35.5
|
L
 -22.7%
H
9.8
35.5
|
Abivax - ADR |
|
5,319.2
|
70.8
|
L
 1.4%
H
70.2
71.8
|
L
 607.8%
H
62.5
72.9
|
L
 856.5%
H
7.4
72.9
|
L
 894.1%
H
5.6
72.9
|
L
 499.3%
H
4.8
72.9
|
L
H
4.8
72.9
|
L
H
4.8
72.9
|
L
H
4.8
72.9
|
Synergy CHC Corp |
|
33.3
|
3.7
|
L
 1.4%
H
3.5
3.7
|
L
 3.7%
H
3.4
4
|
L
 51.9%
H
2.5
4
|
L
 94.2%
H
1.7
4
|
L
H
1.3
4.6
|
L
H
1.3
4.6
|
L
H
1.3
4.6
|
L
H
1.3
4.6
|
iBio Inc |
|
11.4
|
0.7
|
L
 1.5%
H
0.7
0.7
|
L
 -5.4%
H
0.7
0.8
|
L
 -7.9%
H
0.7
0.9
|
L
 -12.5%
H
0.7
1.1
|
L
 -12.5%
H
0.7
1.1
|
L
 -12.5%
H
0.7
1.1
|
L
 -12.5%
H
0.7
1.1
|
L
 -12.5%
H
0.7
1.1
|